References Introduction

The content on this page is a resource for physicians, practice managers, and their staff. To manage a medical practice, you need certain tools, like coding and billing materials, details about payers, and prescribing information. Whether you have an established practice or you are just starting, these resources can help you and your staff.


Medicare Announcements. This section contains a variety of pertinent articles related to Medicare, billing, electronic forms, and health care.


Practice Resources. This section contains forms that may be helpful in tracking your practice's inventory of REMICADE®, policies for key payers you work with, important telephone numbers, and a sample business associate contract.

Infusion Resources. Here, you will find help with documenting infusion visits as well as a tool to track infusions with REMICADE®.

These are just some of the resources you can use to help your practice manage therapy with REMICADE®. This is not an all-inclusive compilation of resources. You should talk to others within your office, hospital, or specialty association to see if there are additional tools that can help you in managing your practice.


RemiStart®. RemiStart® is a patient rebate program that supports your access to REMICADE® (infliximab). For eligible patients, RemiStart® can provide a rebate for your medication out-of-pocket costs, including deductible, co-payment, and co-insurance. If eligible, patients will be responsible for $50 per infusion and will receive a rebate for the remaining medication out-of-pocket costs, for up to 12 months from the first eligible date of service or a maximum annual benefit of $8000, whichever comes first. Eligible patients must be beginning or currently receiving treatment with REMICADE® and must have commercial insurance that covers medication costs for REMICADE®. Patients enrolled in Medicare, Medicaid, or other federally funded programs are not eligible to participate. To enroll, patients should submit a completed enrollment form (editable) to RemiStart®. Click to view the RemiStart® Flashcard and Medication Guide. For additional information, including eligibility and restrictions, please visit RemiStart.com.

If your patient's EOB does not indicate treatment with REMICADE®, click here to download a Clarification Fax that you can complete and submit with the EOB.


RemiStart® Extended Access Program. RemiStart® Extended Access is a patient rebate program for those who have participated in the RemiStart® Program and have exhausted the 12 months in the program. In order to be eligible for Extended Access, patients must have met the eligibility requirements of the RemiStart® Program. If eligible, patients will be responsible for $50 per infusion and will receive a rebate for the remaining medication out-of-pocket costs, for up to 12 months from the re-enrollment date or a maximum annual benefit of $8000, whichever comes first. To enroll, patients should submit a completed enrollment form (editable) to the RemiStart® Extended Access Program. Click to view the RemiStart® Flashcard and Medication Guide.

If your patient's EOB does not indicate treatment with REMICADE®, click here to download a Clarification Fax that you can complete and submit with the EOB.

January 1, 2014